Impact of social deprivation on cancer occurrence and cardiovascular events in systemic sclerosis
Open Access
- 15 June 2026
- journal article
- Published by Oxford University Press (OUP) in Rheumatology Advances in Practice
- Vol. 10 (3)
Abstract
Objectives: Cardiovascular events (CVEs) and malignancy are important non-disease-related causes of mortality in SSc. We evaluated secondary care utilisation and impact of deprivation on comorbidity patterns in SSc in England. Methods: We analysed secondary care service utilisation in SSc using Hospital Episode Statistics for England for 2024. Cases were linked to Index of Multiple Deprivation deciles. Myocardial infarction (MI), lung cancer, breast cancer, melanoma rates and short-term all-cause mortality were explored, alongside comparisons with SLE and RA. Results: In 2024, ≈6000 people with SSc (84.6% female, 70.8% between 51 and 80 years of age, 73.3% White ethnicity) accessed secondary healthcare in England. Older SSc patients were overrepresented in less-deprived postcodes (P < 0.001). MI, lung cancer, breast cancer and melanoma were more common in SSc compared with unmatched estimates in the general population. Lung cancer was more frequent among less-deprived patients (P < 0.001). The all-cause mortality attrition rate was ≈3% in SSc over 3 months (30.8% with lung cancer and >60% with melanoma). Rates of breast cancer were higher in SSc compared with SLE (P = 0.014) and RA (P = 0.012). There was a higher rate of lung cancer in SSc compared with SLE (P < 0.001). Melanoma rates were similar across diseases (≈0.2%). Conclusion: Secondary care utilisation in SSc suggests less deprived SSc patients are older. All-cause mortality is higher in SSc patients receiving cancer care. Cancer occurrence is higher in SSc compared with SLE and RA. Our findings might support healthcare services planning and cancer screening for SSc in England.Keywords
Funding Information
- Wellcome Trust Early Career Award (316390/Z/24/Z)
This publication has 19 references indexed in Scilit:
- Cancer inequalities in the United Kingdom and the data used to measure them: a scoping reviewThe Lancet Regional Health - Europe, 2025
- Systemic sclerosis and cancer in the UK: an epidemiological analysis using the clinical practice research datalinkRheumatology, 2024
- Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UKThe Lancet, 2023
- Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019Autoimmunity Reviews, 2023
- Age specific trends in mortality disparities by socio-economic deprivation in small geographical areas of England, 2002-2018: A retrospective registry studyThe Lancet Regional Health - Europe, 2021
- Risk of death among people with rare autoimmune diseases compared with the general population in England during the 2020 COVID-19 pandemicRheumatology, 2020
- Epidemiology of systemic sclerosis in the UK: an analysis of the Clinical Practice Research DatalinkRheumatology, 2020
- The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research DatalinkClinical Rheumatology, 2018
- Systemic sclerosisThe Lancet, 2017
- SclerodermaNew England Journal of Medicine, 2009